Literature DB >> 30115428

DNA methylation signatures: Biomarkers of drug and alcohol abuse.

Dolly Mahna1, Sanjeev Puri2, Shweta Sharma3.   

Abstract

DNA sequence is a powerful tool that can be used for an individual's identification and investigation of various abnormalities in the genome. However, recent studies have identified other heritable changes by epigenetic mechanisms that cause changes in gene expression without altering the DNA sequence itself. In particular, DNA methylation mediates long-lasting changes in gene promoters, which makes it an appealing epigenetic mechanism to study variation in methylation status that characterizes the extent of drug abuse. We summarize recent findings on methylation alterations in a number of genes caused by various drugs including cocaine, opioids, cannabinoids, amphetamine, phenobarbital, and alcohol in various human and animal model studies. Additionally, a minimal discussion of the basic concepts of methylation is provided. The determination of possible DNA methylation alterations can assist in finding the cause and circumstances of death or ailment, and gene markers can be potentially used as biomarkers in the future.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Alcohol; DNA methylation; Drug of abuse; Epigenetics; Gene promoters; Hypermethylation

Mesh:

Substances:

Year:  2018        PMID: 30115428     DOI: 10.1016/j.mrrev.2018.06.002

Source DB:  PubMed          Journal:  Mutat Res Rev Mutat Res        ISSN: 1383-5742            Impact factor:   5.657


  14 in total

Review 1.  Origins of human disease: the chrono-epigenetic perspective.

Authors:  Edward Saehong Oh; Art Petronis
Journal:  Nat Rev Genet       Date:  2021-04-26       Impact factor: 53.242

Review 2.  Changes in Alcohol Use after Metabolic and Bariatric Surgery: Predictors and Mechanisms.

Authors:  Valentina Ivezaj; Stephen C Benoit; Jon Davis; Scott Engel; Celia Lloret-Linares; James E Mitchell; M Yanina Pepino; Ann M Rogers; Kristine Steffen; Stephanie Sogg
Journal:  Curr Psychiatry Rep       Date:  2019-08-13       Impact factor: 5.285

3.  Dopaminylation in Psychostimulant Use Disorder Protects Against Psychostimulant Seeking Behavior by Normalizing Nucleus Accumbens (NAc) Dopamine Expression.

Authors:  Kenneth Blum; Mark S Gold; Jean L Cadet; David Baron; Abdalla Bowirrat; Panayotis K Thanos; Raymond Brewer; Rajendra D Badgaiyan; Marjorie C Gondré-Lewis
Journal:  Curr Psychopharmacol       Date:  2021-01-08

Review 4.  The epigenetic legacy of illicit drugs: developmental exposures and late-life phenotypes.

Authors:  Nicole M Wanner; Mathia L Colwell; Christopher Faulk
Journal:  Environ Epigenet       Date:  2019-11-13

Review 5.  Genetic impacts on DNA methylation: research findings and future perspectives.

Authors:  Sergio Villicaña; Jordana T Bell
Journal:  Genome Biol       Date:  2021-04-30       Impact factor: 13.583

Review 6.  Epigenetic alterations and genetic variations of angiotensin-converting enzyme 2 (ACE2) as a functional receptor for SARS-CoV-2: potential clinical implications.

Authors:  Anvarsadat Kianmehr; Isabella Faraoni; Omer Kucuk; Abdolkarim Mahrooz
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2021-05-03       Impact factor: 3.267

Review 7.  Alcohol-Related Liver Disease: Basic Mechanisms and Clinical Perspectives.

Authors:  Szu-Yi Liu; I-Ting Tsai; Yin-Chou Hsu
Journal:  Int J Mol Sci       Date:  2021-05-13       Impact factor: 5.923

8.  Epigenetic Effects Mediated by Antiepileptic Drugs and their Potential Application.

Authors:  Fan-Cheng Kong; Chun-Lai Ma; Ming-Kang Zhong
Journal:  Curr Neuropharmacol       Date:  2020       Impact factor: 7.363

9.  Perspective: Quality Versus Quantity; Is It Important to Assess the Role of Enhancers in Complex Disease from an In Vivo Perspective?

Authors:  Andrew R McEwan; Alasdair MacKenzie
Journal:  Int J Mol Sci       Date:  2020-10-23       Impact factor: 5.923

10.  Association between neuropathic pain characteristics and DNA methylation of transient receptor potential ankyrin 1 in human peripheral blood.

Authors:  Shiho Takenaka; Norihiko Sukenaga; Masaki Ohmuraya; Yuka Matsuki; Lynn Maeda; Yumiko Takao; Munetaka Hirose
Journal:  Medicine (Baltimore)       Date:  2020-02       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.